{"transactions":[{"id":827947,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Prin Fin & Acct Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T21:17:26.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":262635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 24, 2026 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued emmployment through the applicable vesting date."}],"balance_after":262635,"derivative":{"exercise_price":1.36,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":262635},"source":{"system":"sec-edgar","filing":"0001193125-26-124380","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000119312526124380/ownership.xml","form_type":"4"}},{"id":827946,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Prin Fin & Acct Officer"}}],"security":"Common Stock","published_at":"2026-03-25T21:17:26.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":109461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 25% on March 31, 2026, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":512882,"source":{"system":"sec-edgar","filing":"0001193125-26-124380","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000119312526124380/ownership.xml","form_type":"4"}},{"id":1182386,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T13:04:17.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":263782,"price":0.98,"value":258506.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31,2025 and the remainder vesting in 36 equal monthly instalments thereafter subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":263782,"derivative":{"exercise_price":0.98,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":263782},"source":{"system":"sec-edgar","filing":"0000950170-25-048902","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000095017025048902/ownership.xml","form_type":"4"}},{"id":1322516,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-23T21:26:34.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option vest in full on December 23, 2025, subject to the Reporting Person's continued employment through the vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.67,"expiration_date":"2034-12-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-139598","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000095017024139598/ownership.xml","form_type":"4"}},{"id":1558175,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2024-03-28T20:31:43.000Z","date":"2024-03-26","kind":"grant","planned":false,"acquired":true,"shares":131484,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":398421,"source":{"system":"sec-edgar","filing":"0000950170-24-038097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000095017024038097/ownership.xml","form_type":"4"}},{"id":1735958,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-11-17T21:16:45.000Z","date":"2023-11-15","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on November 14, 2024, subject to the Reporting Person's continued employment through the vesting date."}],"balance_after":266937,"source":{"system":"sec-edgar","filing":"0001209191-23-055744","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123055744/doc4.xml","form_type":"4"}},{"id":1772495,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-27T22:37:45.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.87,"value":4675.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.87 per share."}],"balance_after":226937,"source":{"system":"sec-edgar","filing":"0001209191-23-050686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123050686/doc4.xml","form_type":"4"}},{"id":1773743,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-25T21:05:30.000Z","date":"2023-09-25","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.77,"value":8850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased all 5,000 shares of common stock in the open market at a price of $1.77 per share."}],"balance_after":224437,"source":{"system":"sec-edgar","filing":"0001209191-23-050495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123050495/doc4.xml","form_type":"4"}},{"id":1774449,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-22T23:35:51.000Z","date":"2023-09-22","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":1.7397,"value":4349.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased all 2,500 shares of common stock in the open market at a price of $1.7397 per share."}],"balance_after":219437,"source":{"system":"sec-edgar","filing":"0001209191-23-050433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123050433/doc4.xml","form_type":"4"}},{"id":1784423,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-09-08T21:01:18.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":93896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that are fully vested."}],"balance_after":211937,"source":{"system":"sec-edgar","filing":"0001209191-23-048816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123048816/doc4.xml","form_type":"4"}},{"id":1936445,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-28T20:45:11.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":157257,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In accordance with the terms of the Pyxis Oncology, Inc. 2019 Equity and Incentive Plan (the \"Plan\"), the Board of Directors of Pyxis Oncology, Inc. approved a stock option repricing pursuant to which option awards granted under the Plan were amended to reduce the exercise price to $2.21 per share, the closing stock price on the date of Board approval. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the terms of the Pyxis Oncology, Inc. 2019 Equity and Incentive Plan (the \"Plan\"), the Board of Directors of Pyxis Oncology, Inc. approved a stock option repricing pursuant to which option awards granted under the Plan were amended to reduce the exercise price to $2.21 per share, the closing stock price on the date of Board approval. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vested 25% on August 23, 2022, and then vests in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":157257,"derivative":{"exercise_price":2.21,"expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":157257},"source":{"system":"sec-edgar","filing":"0001209191-23-021411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123021411/doc4.xml","form_type":"4"}},{"id":1936444,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-28T20:45:11.000Z","date":"2023-03-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":157257,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In accordance with the terms of the Pyxis Oncology, Inc. 2019 Equity and Incentive Plan (the \"Plan\"), the Board of Directors of Pyxis Oncology, Inc. approved a stock option repricing pursuant to which option awards granted under the Plan were amended to reduce the exercise price to $2.21 per share, the closing stock price on the date of Board approval. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the terms of the Pyxis Oncology, Inc. 2019 Equity and Incentive Plan (the \"Plan\"), the Board of Directors of Pyxis Oncology, Inc. approved a stock option repricing pursuant to which option awards granted under the Plan were amended to reduce the exercise price to $2.21 per share, the closing stock price on the date of Board approval. Except for the modified exercise price, all other terms and conditions of each of the option awards will continue as set forth in the Plan and the applicable award agreements."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options vested 25% on August 23, 2022, and then vests in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":8.71,"expiration_date":"2031-07-30","underlying":"Common Stock","underlying_shares":157257},"source":{"system":"sec-edgar","filing":"0001209191-23-021411","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123021411/doc4.xml","form_type":"4"}},{"id":1936443,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-28T20:45:11.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that vest 25% on August 3, 2023, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":88648,"source":{"system":"sec-edgar","filing":"0001209191-23-021411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123021411/doc4.xml","form_type":"4"}},{"id":1936442,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":55981,"kind":"person","name":"Wadhane Jitendra","position":1,"cik":"0001941706","reported_name":"Wadhane Jitendra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2023-03-28T20:45:11.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":29393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 25% on March 24, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date."}],"balance_after":118041,"source":{"system":"sec-edgar","filing":"0001209191-23-021411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782223/000120919123021411/doc4.xml","form_type":"4"}}]}